Dr. Mary Scollay | Jockey Club
Edited press release
The Racing Medication and Testing Consortium (RMTC) has announced its support for postdoctoral training by funding a Fellows Program commencing in 2022.
The need to set up such a program is twofold:
- To promote a sustainable research program with a core focus on anti-doping, including topics related to drug testing, development of new analytical methods with application to racing chemistry, pharmaceuticals pharmacokinetics/pharmacodynamics, forensic toxicology or other related disciplines. The future of equestrian anti-doping programs requires the mentoring of young scientists to become researchers, racing lab directors and industry leaders. Innovation and application of newer, more sophisticated technological advances will come from those young scientists.
- To establish a mechanism for identifying, recruiting and retaining young scientists and encouraging their pursuit of research related to equestrianism, a rigorous anti-doping program and promoting safety is required. Fully advanced for horse racing.
Dr Mary Scollay, Chief Executive Officer and Chief Executive Officer, said: “Recruiting and retaining motivated, highly trained staff and supporting competitive research programs is critical to with anti-doping, drug control and racing safety programs. “The racing industry has a responsibility to attract qualified individuals, support their advanced training, provide incentives for related research programs and promote productivity in laboratories. study.”
Previous relevant research areas include veterinary pharmacology, veterinary or human toxicology, and analytical chemistry. More recently, other disciplines, including genetics, biophysics, and immunology have become involved in anti-doping. Scientists trained in these fields are encouraged to apply for the Fellowship.
Not a subscriber? Click here to subscribe to PDF or daily alerts.
This story was posted in News is shared and tagged anti-doping, Dr. Mary Scollay, education, Postdoctoral Fellow, RMTC.
